You are here: vision-research.eu » News » Newsdetails:

AGTC Earns $10 Million After Reaching Phase I/II Study Milestone

Applied Genetic Technologies Corporation has earned a $10 million payment from Biogen for reaching a milestone outlined in a collaboration deal the companies signed in 2015.